InterVaal is developing a catheter to address the widespread problem of catheter-associated urinary tract infection (CAUTI).

The Product & Advantages

The “buffer zone” of the uniquely designed InterVaal catheter serves to keep the urethra flushed and to mitigate the migration of bacteria. The catheter design reduces the number of urinary tract infections caused by the presence of bacteria along the catheter.

The Team

Sam Lim, CEO: Over 10 years of R&D project management experience in medical device companies

Lu Shan, mechanical engineer: 4 years’ experience in product design, with a specialty in medical devices

Trendlines’ director: Eric Loh


Founded: September 2017
Stage: Technology development
Investors: The Trendlines Group, Trendlines Medical Singapore
IP: Provisional patent application

Background & Market

A urinary tract infection is an infection in the urinary system which includes the urethra, bladder and kidneys. CAUTIs occur due to the presence of bacteria that travel along the catheter and cause infection.


Sam Lim, CEO

InterVaal portfolio card


Font Resize